Aptus Biotech
Contact information
Aptus Biotech
Ana García
Cardenal Herrera Oria 298
Madrid
Madrid
910075622
Areas of activities
- A. Health Biotechnology
- Areas of activity
- Biodrugs
- Biomarkers
- In vitro diagnostics
- Drug delivery
- Drug discovery
- Therapeutic areas
- Cardiovascular diseases and circulatory system
- Infectious diseases
- Inflammatory diseases
- Immunology
- B. Agrifood Biotechnology
- Agriculture / veterinary / environmental
- Animal health / Veterinary
- Food
- Food safety
- D. Services
- R&D services
- Biotechnolgy kits
- Supplies and materials providers
Commissions
Aptus mission is to develop innovative applications based on aptamer technology. The company has developed a portfolio of aptamers with interest in diagnosis and therapy markets and an ultrasensitive biosensing technology named AptaDetect. Based on the aptamers advantages, AptaDetect achieves a high detection capability.
The Aptus priorities are the development of specific applications for the AptaDetect platform.
Products and services
- AptaDetect: biosensing platform for detection and diagnosis of high sensibility
- Aptateca: catalog of aptamers for different applications
- Aptamer Development Service
Biotech Sanitaria
| Product / Service | Type | Therapeutic area | Development phase |
|---|---|---|---|
| CAT-ApMnkQ2 | Biodrugs/ Drugs | Oncología | R&D |
| AptaMnkQ2 | Biodrugs/ Drugs | Oncología | R&D |
| Product / Service | Type | Development phase |
|---|---|---|
| Aptamer development platform | Drug Delivery, Enabling Technologies, Screening/Drug Discovery | R&D |
| Product / Service | Type | Therapeutic area | Development phase |
|---|---|---|---|
| PrediApt | Biomarkers, Diagnostic | Oncología | Preclinical |
| Apta-Leish | Diagnostic | Enfermedades infecciosas | R&D |
| PHITBAC | Diagnostic | Enfermedades infecciosas | R&D |
| AptaDetect-HCV | Diagnostic | Enfermedades infecciosas | R&D |